Department of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Department of Medicine, Division of General Internal Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America.
PLoS One. 2018 Mar 7;13(3):e0193050. doi: 10.1371/journal.pone.0193050. eCollection 2018.
Early diagnosis of influenza infection maximizes the effectiveness of antiviral medicines. Here, we assess the ability for clinical characteristics and rapid influenza tests to predict PCR-confirmed influenza infection in a sentinel, cross-sectional study for influenza-like illness (ILI) in Thailand. Participants meeting criteria for acute ILI (fever > 38°C and cough or sore throat) were recruited from inpatient and outpatient departments in Bangkok, Thailand, from 2009-2014. The primary endpoint for the study was the occurrence of virologically-confirmed influenza infection (based upon detection of viral RNA by RT-PCR) among individuals presenting for care with ILI. Nasal and throat swabs were tested by rapid influenza test (QuickVue) and by RT-PCR. Vaccine effectiveness (VE) was calculated using the case test-negative method. Classification and Regression Tree (CART) analysis was used to predict influenza RT-PCR positivity based upon symptoms reported. We enrolled 4572 individuals with ILI; 32.7% had detectable influenza RNA by RT-PCR. Influenza cases were attributable to influenza B (38.6%), A(H1N1)pdm09 (35.1%), and A(H3N2) (26.3%) viruses. VE was highest against influenza A(H1N1)pdm09 virus and among adults. The most important symptoms for predicting influenza PCR-positivity among patients with ILI were cough, runny nose, chills, and body aches. The accuracy of the CART predictive model was 72.8%, with an NPV of 78.1% and a PPV of 59.7%. During epidemic periods, PPV improved to 68.5%. The PPV of the QuickVue assay relative to RT-PCR was 93.0% overall, with peak performance during epidemic periods and in the absence of oseltamivir treatment. Clinical criteria demonstrated poor predictive capability outside of epidemic periods while rapid tests were reasonably accurate and may provide an acceptable alternative to RT-PCR testing in resource-limited areas.
早期诊断流感感染能最大程度提高抗病毒药物的疗效。在这里,我们评估了临床特征和快速流感检测在泰国流感样疾病(ILI)哨点、横断面研究中预测聚合酶链反应(PCR)确诊流感感染的能力。符合急性 ILI(体温>38°C 伴咳嗽或咽痛)标准的参与者,于 2009 年至 2014 年期间从曼谷的住院部和门诊部招募。该研究的主要终点是出现经病毒学确诊的流感感染(根据 RT-PCR 检测到病毒 RNA 确定),研究对象是因 ILI 就诊的人群。对鼻和咽拭子进行快速流感检测(QuickVue)和 RT-PCR 检测。使用病例检测阴性法计算疫苗效力(VE)。使用分类和回归树(CART)分析基于报告的症状预测流感 RT-PCR 阳性率。我们共纳入 4572 例 ILI 患者;32.7%的患者通过 RT-PCR 检测到可检测的流感 RNA。流感病例归因于流感 B(38.6%)、A(H1N1)pdm09(35.1%)和 A(H3N2)(26.3%)病毒。VE 对 A(H1N1)pdm09 病毒和成人最高。ILI 患者预测流感 PCR 阳性率最重要的症状是咳嗽、流涕、寒战和全身疼痛。CART 预测模型的准确性为 72.8%,阴性预测值为 78.1%,阳性预测值为 59.7%。在流行期,阳性预测值提高到 68.5%。与 RT-PCR 相比,QuickVue 检测的总体阳性预测值为 93.0%,在流行期和无奥司他韦治疗时性能最佳。